Medical Device News Magazine

Medline and Visby Form Distribution Partnership for Game-changing STI Test

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Medline today announced a new partnership with Visby Medical (Visby), an award-winning medical diagnostic company, for distribution of Visby Medical’s Sexual Health Click Test, a groundbreaking Clinical Laboratory Improvement Amendments (CLIA) waived, PCR diagnostic test for sexually transmitted infections (STIs) for women that fits in the palm of your hand.

As STIs are at an all-time high for the sixth consecutive year in the U.S., Medline will bring this new Food and Drug Administration (FDA)-cleared technology to healthcare organizations in all 50 states and across the continuum of care, including urgent care centers, student health centers, women’s health facilities, and community health centers.

The Visby PCR point-of-care device is an all-in-one unit that requires no separate instrument or reader. Designed to provide accurate diagnosis in under 30 minutes, the Visby device enables clinicians to discuss results and prescribe personalized treatment during the patient visit – rather than days later – eliminating the need for presumptive treatment.

“Our partnership with Visby demonstrates our commitment to bringing leading-edge medical innovations to the point of care that revolutionize patient care,” said Doug Sharpe, vice president of Lab Capital at Medline. “Winning several awards for design innovation and excellence, the Visby device is the first PCR test of its kind and gives clinicians a tool to help improve patient outcomes.”

According to a recent study in The Lancet Infectious Diseases, the Visby Medical Sexual Health Click Test is potentially the new gold standard for point-of-care tests for infectious diseases such as STIs in which rapid turnaround is key. As a finalist for the 2022 AACC Disruptive Technology Award, the Visby device has ~97% accuracy or greater for the detection of chlamydia, gonorrhea, and trichomonas, the three most common pathogens that can foster contagion and permanently damage a woman’s reproductive system if left untreated.

“Visby’s development of the world’s first instrument-free handheld PCR platform to accurately and rapidly test for a variety of serious infections is changing how healthcare is delivered, especially in urgent care and women’s health settings,” said Visby Medical Founder and CEO Adam de la Zerda. “Our partnership with Medline will help our innovative testing technology reach clinicians quickly, helping us improve STI containment, prevention, and treatment.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.